Physician profile
Samara B Shipon
NPI 1487893152
$5,925.57
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,899 · 2020: $434 · 2021: $184 · 2022: $54.30 · 2023: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,788.02 | 2019 | |
| Medtronic USA, INC. | $1,534.04 | 2019-2020 | |
| Boston Scientific Corporation | $565.24 | 2019-2023 | |
| Abbott Laboratories | $526.23 | 2019-2023 | Proclaim |
| Tersera Therapeutics LLC | $171.73 | 2019 | |
| Nevro Corp. | $156.49 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $147.49 | 2019-2020 | |
| Avanos Medical | $145.56 | 2019 | |
| Lilly USA, LLC | $137.52 | 2019 | |
| Medtronic, INC. | $108.36 | 2021-2023 | Intellis Adaptivestim |
| Arbor Pharmaceuticals, INC. | $72.87 | 2019 | |
| Sentynl Therapeutics, INC. | $66.14 | 2019 | |
| Daiichi Sankyo INC. | $62.69 | 2019 | |
| Grt US Holding, INC. | $58.65 | 2019-2020 | |
| Pfizer INC. | $55.44 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| West Therapeutics Development, LLC | $41.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $37.70 | 2019 | |
| Shionogi INC | $30.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.34 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $27.79 | 2019 | |
| Forte Bio-Pharma LLC | $27.43 | 2019 | |
| Relievant Medsystems, INC. | $26.54 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.10 | 2019 | |
| Mdd US Operations, LLC | $19.53 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.21 | 2019 | |
| Bioventus LLC | $19.02 | 2020 | |
| Almatica Pharma LLC | $13.47 | 2021 | |
| Zyla Life Sciences, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samara Shipon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.